documents: FDA-1976-N-0520-0011

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1976-N-0520-0011 FDA FDA-1976-N-0520 Eli Lilly & Co. and Bristol-Myers Squibb Co.; Withdrawal of Approval of Three New Drug Applications for Estrogen-Androgen Combination Drugs Notice NWL-Notice of Withdrawl 1998-11-04T05:00:00Z 1998 11     2018-08-02T16:31:49Z   0 0 090000648053be5b

Links from other tables